Upcoming events

Titanium-nitride-oxide bioactive stent: the evidence-based choice in STEMI and NSTEMI patients

With an unrestricted educational grant from HEXACATH

Learning Objectives

  • To understand the short- and long- term benefits offered with titanium-nitride-oxide bioactive stents in the setting of STEMI and NSTEMI patients
  • To appreciate the strong advantages of titanium-nitride-oxide bioactive stents offering a reduced dual-antiplatelet therapy duration
  • To evaluate the clinical results of different active stent technologies such as limus and titanium-nitride-oxide coated stents

Presentations available when logged in:

  • Large scale TITAN2 spanish registry in STEMI and NSTEMI patients
  • BASE-ACS randomised study comparing the titanium-nitride-oxide bioactive Titan2 stent with the Everolimus-eluting stent Xience V: a 3-year follow-up
  • Introduction and objectives
  • What is the role of nitride oxide in the efficacy of Titan stent in patients with acute coronary syndromes?
  • The latest active stent technologies (bioactive and drug-eluting stents) and the complex problem of dual-antiplatelet therapy management in STEMI a...
  • The new ESC 2012 STEMI guidelines: bioactive stents should be preferred over DES
  • Take-home message